Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Tsumagari

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Chromosoma|November 30, 2006
Hybridization analysis of D4Z4 repeat arrays linked to FSHDMelanie Ehrlich, Kesmic Jackson, Koji Tsumagari, et al.
World Journal of Stem Cells|November 27, 2014
Stem cell biology in thyroid cancer: Insights for novel therapiesParisha Bhatia, Koji Tsumagari, Zakaria Y Abd Elmageed, et al.
Breast Cancer (Tokyo, Japan)|August 20, 2005
Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genesKoji Tsumagari, Kazuo Chijiiwa, Hisaki Nagai, et al.
The Journal of Surgical Research|July 2, 2016
Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literatureMuhammad Ahmed Farooq Anwar, Fadi Murad, Erin Dawson, et al.
Plos One|November 19, 2011
DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophyBenjamin D Pope, Koji Tsumagari, Dana Battaglia, et al.
Nucleic Acids Research|February 19, 2008
Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancersKoji Tsumagari, Lixin Qi, Kesmic Jackson, et al.
Anticancer Research|October 15, 2013
A novel mouse model of metastatic thyroid carcinoma using human adipose tissue-derived stromal/stem cellsEmad Kandil, Adam Hauch, Paul Friedlander, et al.
Cancer Biology & Therapy|April 23, 2005
A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in othersRie Nishiyama, Lixin Qi, Koji Tsumagari, et al.
Cancer Letters|July 26, 2015
Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancerKoji Tsumagari, Zakaria Y Abd Elmageed, Andrew B Sholl, et al.
The Journal of Surgical Research|April 23, 2013
Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathwaysEmad Kandil, Koji Tsumagari, Jingjing Ma, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Chromosoma|November 30, 2006
Hybridization analysis of D4Z4 repeat arrays linked to FSHDMelanie Ehrlich, Kesmic Jackson, Koji Tsumagari, et al.
World Journal of Stem Cells|November 27, 2014
Stem cell biology in thyroid cancer: Insights for novel therapiesParisha Bhatia, Koji Tsumagari, Zakaria Y Abd Elmageed, et al.
Breast Cancer (Tokyo, Japan)|August 20, 2005
Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genesKoji Tsumagari, Kazuo Chijiiwa, Hisaki Nagai, et al.
The Journal of Surgical Research|July 2, 2016
Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literatureMuhammad Ahmed Farooq Anwar, Fadi Murad, Erin Dawson, et al.
Plos One|November 19, 2011
DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophyBenjamin D Pope, Koji Tsumagari, Dana Battaglia, et al.
Nucleic Acids Research|February 19, 2008
Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancersKoji Tsumagari, Lixin Qi, Kesmic Jackson, et al.
Anticancer Research|October 15, 2013
A novel mouse model of metastatic thyroid carcinoma using human adipose tissue-derived stromal/stem cellsEmad Kandil, Adam Hauch, Paul Friedlander, et al.
Cancer Biology & Therapy|April 23, 2005
A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in othersRie Nishiyama, Lixin Qi, Koji Tsumagari, et al.
Cancer Letters|July 26, 2015
Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancerKoji Tsumagari, Zakaria Y Abd Elmageed, Andrew B Sholl, et al.
The Journal of Surgical Research|April 23, 2013
Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathwaysEmad Kandil, Koji Tsumagari, Jingjing Ma, et al.
Pageof 3